Company: MVIS
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-021931
Chunk: 150

Company: MICROVISION, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 1
Chunk 150
---
 AND LOSS INSTRUMENTS

    (in thousands) 
    2025  
    2024  
    2025  
    2024 

    Three Months Ended  
    Nine Months Ended 

    September 30,  
    September 30, 
  
    (in thousands) 
    2025  
    2024  
    2025  
    2024 
  
    Unrealized gain on derivative liability 
    $1,059  
    $-  
    $3,853  
    $- 

    15

Fair
Value Measurements

The
fair value of the derivative liability is determined utilizing a “with and without” method, in which the fair value is calculated
as the difference in the fair value of the entire hybrid instrument and the fair value of the instrument excluding the bifurcated derivative
features.

The
valuation inputs hierarchy classification for liabilities measured at fair value on a recurring basis are summarized below as of September
30, 2025 and December 31, 2024 (in thousands). See Note 5. Investment Securities, Available-For-Sale and Fair Value Measurements,
for discussion of the fair value level hierarchy.

 SCHEDULE
OF HIERARCHY LIABILITIES FAIR VALUE

    As of September 30, 2025 
    Level 1  
    Level 2  
    Level 3 
  
    Derivative liability 
    $-  
    $-  
    $1,856 
  
    Total 
    $-  
    $-  
    $1,856 

    As of December 31, 2024 
    Level 1  
    Level 2  
    Level 3 
  
    Derivative liability 
    $-  
    $-  
    $14,581 
  
    Total 
    $-  
    $-  
    $14,581 

The
table below lists the inputs and assumptions for the Company’s valuations as of September 30, 2025 and December 31, 2024:

 SCHEDULE
OF REVALUATION DERIVATIVE LIABILITY

    September 30,  
    December 31, 

    2025  
    2024 
  
    Expected term (years) 
     1.0  
     1.75 
  
    Risk-free